Filippo Sladojevich

Filippo Sladojevich is a highly experienced scientist in drug development and solid phase synthesis, with a career spanning over a decade in prominent research roles. At Roche, from October 2017 to October 2023, Filippo advanced from Senior Scientist to Senior Principal Scientist, refining expertise in various aspects of drug development. Prior experience includes serving as a Research Scientist at Philochem AG and holding multiple postdoctoral positions at prestigious institutions such as ETH Zurich, Harvard University, and the University of Oxford. Filippo holds a PhD in Chemistry from Università degli Studi Firenze, underscoring a solid academic foundation.